Related Experiment Video
Updated: Sep 11, 2025

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
Jian Guan1,2, Shenglin Wu3, Renyi Liang4
1Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.
Abstract:
Determining the critical elements in melanoma stem cell growth could aid in preventing the development of malignant cancer. The purpose of this study was to illustrate how FBXO31 affects the stemness, invasion, and migratory properties of melanoma stem cells. Side population (SP) cells with tumor stem cell characteristics were sorted from A375 melanoma cells. The mRNA and protein expression levels of FBXO31 in SP cells were detected using molecular techniques. FBXO31 was then transfected into SP cells, and the proportion of CD147 (+) cells in SP cells was detected by flow cytometry. FBXO31 was also transfected into CD147 (+) cells, and their spheroid formation, migration, and invasion ability were measured. Additionally, CD147 (-) and CD147 (+) cells were inoculated into nude mice to assess the effect of FBXO31 on tumor growth and metastasis. The findings demonstrate that FBXO31 is downregulated in SP cells. Upon FBXO31 transfection, the proportion of CD147 (+) cells sorted from SP cells decreased. CD147 (+) cells exhibit higher stemness characteristics, migration, and invasion abilities than CD147 (-) cells. However, these characteristics were markedly suppressed following FBXO31 transfection in CD147 (+) cells. In vivo experiment further showed that CD147 (+) cells promoted tumor growth and metastasis, while after transfection with FBXO31, tumor proliferation and metastatic abilities were inhibited. Overall, FBXO31 inhibits the migration, invasion, and stemness characteristics of CD147 (+) melanoma stem cells.
Insights
FBXO31 suppresses melanoma stem cell migration, invasion, and stemness. This finding is crucial for understanding and potentially preventing malignant cancer development by targeting melanoma stem cells.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Melanoma stem cells drive cancer progression.
- Identifying factors regulating melanoma stem cell properties is critical for therapeutic strategies.
Purpose of the Study:
- To investigate the role of FBXO31 in regulating the stemness, invasion, and migration of melanoma stem cells.
- To elucidate the relationship between FBXO31 and CD147 expression in melanoma stem cells.
Main Methods:
- Isolation of melanoma stem cells (SP cells) from A375 cells.
- Detection of FBXO31 expression and manipulation via transfection.
- Flow cytometry to assess CD147 expression.
- In vitro assays for spheroid formation, migration, and invasion.
- In vivo studies in nude mice to evaluate tumor growth and metastasis.
Main Results:
- FBXO31 expression was found to be downregulated in melanoma stem cells.
- FBXO31 transfection reduced the proportion of CD147-positive cells.
- CD147-positive cells exhibited enhanced stemness, migration, and invasion, which were suppressed by FBXO31.
- In vivo experiments confirmed that FBXO31 inhibits tumor growth and metastasis driven by CD147-positive cells.
Conclusions:
- FBXO31 plays an inhibitory role in the migration, invasion, and stemness of CD147-positive melanoma stem cells.
- Targeting FBXO31 may represent a potential therapeutic approach for melanoma treatment by reducing cancer stem cell activity.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mesenchymal Stem Cells